Clinical Trials Browser

Phase 1/2 × Advanced Malignancies × pembrolizumab × Clear all

NCT04837196 2025-08-08

Study of ASP7517 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors Expressing WT1 Antigen

Phase 1/2 Completed

24 enrolled 47 charts

Advanced Malignancies